Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Survey Finds High Trust in Pharmacists to Expand Role in Patient Care
01/17/2022
Respondents indicated trust in pharmacists to fill in gaps in primary care, expand their roles to include more patient care activities, and assist with implementing value-based payment models.
Respondents indicated trust in pharmacists to fill in gaps in primary care, expand their roles to include more patient care activities, and assist with implementing value-based payment models.
Respondents indicated trust in...
01/17/2022
Pharmacy Learning Network
News
Opioid Tablets Recalled
01/13/2022
Opioid tablets are being recalled after samples yielded an out-of-specification impurity result at 18-month stability testing.
Opioid tablets are being recalled after samples yielded an out-of-specification impurity result at 18-month stability testing.
Opioid tablets are being...
01/13/2022
Pharmacy Learning Network

Advertisement

News
Eye Solution Recalled
01/13/2022
Eye solution is under a Class III recall for failing to meet stability specifications.
Eye solution is under a Class III recall for failing to meet stability specifications.
Eye solution is under a Class...
01/13/2022
Pharmacy Learning Network
News
Antibiotic Capsules Recalled
01/13/2022
A Class II recall has been issued for 42,698 bottles of a prescription antibiotic that failed to meet impurity/degradation specifications.
A Class II recall has been issued for 42,698 bottles of a prescription antibiotic that failed to meet impurity/degradation specifications.
A Class II recall has been...
01/13/2022
Pharmacy Learning Network
News
Postoperative Pain Outcomes Superior With Nonopioids vs Opioids
01/10/2022
Compared to codeine, nonsteroidal anti-inflammatory drugs were linked to better pain scores and fewer adverse effects in adults receiving treatment for postoperative pain.
Compared to codeine, nonsteroidal anti-inflammatory drugs were linked to better pain scores and fewer adverse effects in adults receiving treatment for postoperative pain.
Compared to codeine,...
01/10/2022
Pharmacy Learning Network

Advertisement

News
Multiple Hypotension Drugs Recalled
01/07/2022
Two vasoconstrictors are being recalled over sterility concerns.
Two vasoconstrictors are being recalled over sterility concerns.
Two vasoconstrictors are being...
01/07/2022
Pharmacy Learning Network
News
Vasopressor Injection Recalled
01/07/2022
More than 43,000 bags of epinephrine are under a Class II recall.
More than 43,000 bags of epinephrine are under a Class II recall.
More than 43,000 bags of...
01/07/2022
Pharmacy Learning Network
News
Sodium Bicarbonate IV Bags Recalled
01/07/2022
A prescription alkalinizing agent is under a Class II recall due to lack of sterility assurance.
A prescription alkalinizing agent is under a Class II recall due to lack of sterility assurance.
A prescription alkalinizing...
01/07/2022
Pharmacy Learning Network

Advertisement

News
OTC Antihistamine Tablets Recalled
12/29/2021
A medication used to relieve allergy symptoms is being recalled for failure to meet impurity/degradation specifications.
A medication used to relieve allergy symptoms is being recalled for failure to meet impurity/degradation specifications.
A medication used to relieve...
12/29/2021
Pharmacy Learning Network
News
Antibiotic Recalled
12/29/2021
Over 100,000 bottles of penicillin V potassium are under a Class II recall due to subpotency.
Over 100,000 bottles of penicillin V potassium are under a Class II recall due to subpotency.
Over 100,000 bottles of...
12/29/2021
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use